Cargando…

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

BACKGROUND/AIMS: The most commonly used immunosuppressant therapy after liver transplantation (LT) is a combination of tacrolimus and steroid. Basiliximab induction has recently been introduced; however, the most appropriate immunosuppression for hepatocellular carcinoma (HCC) patients after LT is s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ju-Yeun, Kim, Yul Hee, Yi, Nam-Joon, Kim, Hyang Sook, Lee, Hye Suk, Lee, Byung Koo, Kim, Hyeyoung, Choi, Young Rok, Hong, Geun, Lee, Kwang-Woong, Suh, Kyung-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099335/ https://www.ncbi.nlm.nih.gov/pubmed/25032186 http://dx.doi.org/10.3350/cmh.2014.20.2.192

Ejemplares similares

Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Yoo, Tae, et al.
Publicado: (2016)

Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
por: Park, Min-Su, et al.
Publicado: (2014)

Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2015)

Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: A case report
por: Nugroho, Adianto, et al.
Publicado: (2018)

Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma
por: Jang, Ye-Rang, et al.
Publicado: (2015)

Recurrence in patients with totally necrotic nodules of hepatocellular carcinoma after liver transplantation: “totally” an inaccurate description
por: Kim, Jiyoung, et al.
Publicado: (2023)

Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
por: Suh, Suk-Won, et al.
Publicado: (2016)

Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging
por: Choi, YoungRok, et al.
Publicado: (2015)

Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma
por: Kim, Jong Man, et al.
Publicado: (2018)

Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume
por: Hong, Geun, et al.
Publicado: (2014)

Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection
por: Kim, Hyo-Sin, et al.
Publicado: (2021)

Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases
por: Park, Min-Su, et al.
Publicado: (2014)

False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients
por: Lee, Hongeun, et al.
Publicado: (2017)

Fatigue and related factors after liver transplantation
por: Hong, Kwangpyo, et al.
Publicado: (2015)

The Model for End-Stage Liver Disease Score-Based System Predicts Short Term Mortality Better Than the Current Child-Turcotte-Pugh Score-Based Allocation System during Waiting for Deceased Liver Transplantation
por: Hong, Geun, et al.
Publicado: (2013)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Impact of tumor size on hepatectomy outcomes in hepatocellular carcinoma: a nationwide propensity score matching analysis
por: Hong, Suk Kyun, et al.
Publicado: (2022)

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
por: Kim, Jong Man, et al.
Publicado: (2016)

Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2017)

Pure laparoscopic right hepatectomy in a patient with situs inversus totalis: A case report
por: Hong, Suk Kyun, et al.
Publicado: (2017)

Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma
por: Lee, Hwi Yeol, et al.
Publicado: (2021)

Metastatic follicular struma ovarii complicating pregnancy: a case report and review of the literature
por: Lee, Woohyung, et al.
Publicado: (2012)

Outcomes of Split Liver Transplantation vs Living Donor Liver Transplantation in Pediatric Patients: A 5-Year Follow-Up Study in Korea
por: Yoon, Kyung Chul, et al.
Publicado: (2022)

Validation for models for tumor recurrence after liver transplantation in hepatectomy patients
por: Kim, Sung Joon, et al.
Publicado: (2022)

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020)

Efficacy of Liver Resection for Single Large Hepatocellular Carcinoma in Child-Pugh A Cirrhosis: Analysis of a Nationwide Cancer Registry Database
por: Hong, Suk Kyun, et al.
Publicado: (2021)

Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2020)

Posttransplant sequential adrenal and spine metastasis of hepatocellular carcinoma responsive to combined regorafenib and radiotherapy: a case report
por: Kim, Jae-Yoon, et al.
Publicado: (2023)

Corrigendum: Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2021)

Long‐term outcomes of laparoscopic versus open liver resection for intrahepatic combined hepatocellular‐cholangiocarcinoma with propensity score matching
por: Lee, Seung Jae, et al.
Publicado: (2022)

Alteration of MRP2 expression and the graft outcome after liver transplantation
por: Yi, Nam-Joon, et al.
Publicado: (2018)

Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation
por: Kim, Min Seob, et al.
Publicado: (2022)

Long-Term Outcomes of Abdominal Wall Reconstruction with Expanded Polytetrafluoroethylene Mesh in Pediatric Liver Transplantation
por: Kim, Jiyoung, et al.
Publicado: (2021)

Tailored Prediction Model of Survival after Liver Transplantation for Hepatocellular Carcinoma
por: Jamtani, Indah, et al.
Publicado: (2021)

Long Term Outcomes of Pediatric Liver Transplantation According to Age
por: Byun, Jeik, et al.
Publicado: (2014)

Pure Laparoscopic Versus Open Right Hepatectomy in Living Liver Donors: Graft Weight Discrepancy
por: Seo, Jiwon, et al.
Publicado: (2022)

Pretransplantation fetal-maternal microchimerism in pediatric liver transplantation from mother
por: Yi, Nam-Joon, et al.
Publicado: (2017)

A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma
por: Kim, Si-Cho, et al.
Publicado: (2023)

The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas
por: Lee, KyuHo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pvpfhtel21uc7ffmpu41def3g2